Trellus Health PLC
LSE:TRLS
Trellus Health PLC
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2021-05-28. The firm is commercializing digital chronic condition management solutions for employers and health plans that utilize the scientifically validated Gaining Resilience Through Transitions (GRITT) resilience-based methodology and a proprietary HIPAA compliant technology platform called TrellusElevate, to coordinate and deliver personalized care remotely through telemedicine. The firm is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2021-05-28. The firm is commercializing digital chronic condition management solutions for employers and health plans that utilize the scientifically validated Gaining Resilience Through Transitions (GRITT) resilience-based methodology and a proprietary HIPAA compliant technology platform called TrellusElevate, to coordinate and deliver personalized care remotely through telemedicine. The firm is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
